Treasury Stock


Novo Nordisk A/S - Share repurchase programme

On 31 January 2008 Novo Nordisk initiated its share repurchase
programme in accordance with the provisions of the European
Commission's regulation no 2273/2003 of 22 December 2003, also
referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an
amount of up to DKK 2 billion in the period from 31 January 2008 to 6
August 2008.

Since the announcement as of 17 March 2008, the following
transactions have been made under the programme:


                               Number of    Average     Transaction
                                shares   purchase price value, DKK
Accumulated, last announcement 1,657,907                541,310,698
17 Mar 2008                       50,000       317.7900  15,889,500
18 Mar 2008                       50,000       320.9500  16,047,500
19 Mar 2008                       50,000       323.4900  16,174,500
25 Mar 2008                       50,000       326.1300  16,306,500
26 Mar 2008                       50,000       319.6500  15,982,500
27 Mar 2008                       50,000       318.0200  15,901,000
28 Mar 2008                       50,000       315.6000  15,780,000
Accumulated, 2008              2,007,907                653,392,198


With the transactions stated above, Novo Nordisk owns a total of
26,968,090 treasury shares, corresponding to 4.2% of the share
capital. The total amount of shares in the company is 646,960,000
including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes
care. In addition, Novo Nordisk has a leading position within areas
such as haemostasis management, growth hormone therapy and hormone
replacement therapy. Novo Nordisk manufactures and markets
pharmaceutical products and services that make a significant
difference to patients, the medical profession and society. With
headquarters in Denmark, Novo Nordisk employs approximately 26,000
employees in 80 countries, and markets its products in 179 countries.
Novo Nordisk's B shares are listed on the stock exchanges in
Copenhagen and London. Its ADRs are listed on the New York Stock
Exchange under the symbol 'NVO'. For more information, visit
novonordisk.com.

Further information:

Media:                 Investors:

Outside North America: Outside North America:
Elin K Hansen          Mads Veggerby Lausten
Tel: (+45) 4442 3450   Tel: (+45) 4443 7919
ekh@novonordisk.com    mlau@novonordisk.com

                       Hans Rommer
                       Tel: (+45) 4442 4765
                       hrmm@novonordisk.com

In North America:      In North America:
Sean Clements          Christian Qvist Frandsen
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com   cqfr@novonordisk.com


Stock Exchange Announcement no 17 / 2008